VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas

Completed · Phase 1

Conditions studied: Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of VNP40101M in treating patients who have advanced solid tumors or lymphomas.

Key facts

Study ID

NCT00025129

Run by

Vion Pharmaceuticals

Starts

2001-03-01

Expected to finish

2004-05-01

Last updated by the study team

2013-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arizona Clinical Research Center — Tucson, Arizona, United States
• Yale Comprehensive Cancer Center — New Haven, Connecticut, United States
• Veterans Affairs Medical Center - West Haven — West Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.